Formulation and Characterization of Carvedilol Leciplex for Glaucoma Treatment: In-Vitro, Ex-Vivo and In-Vivo Study
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Formulation and Characterization of Carvedilol Leciplex for Glaucoma Treatment: In-Vitro, Ex-Vivo and In-Vivo Study
Authors
Keywords
-
Journal
Pharmaceutics
Volume 10, Issue 4, Pages 197
Publisher
MDPI AG
Online
2018-10-23
DOI
10.3390/pharmaceutics10040197
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Corneal permeation properties of a charged lipid nanoparticle carrier containing dexamethasone
- (2017) Junfeng Ban et al. International Journal of Nanomedicine
- Designing lipid nanoparticles for topical ocular drug delivery
- (2017) Jesus Alvarez-Trabado et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Chitosan-based nano-in-microparticle carriers for enhanced oral delivery and anticancer activity of propolis
- (2016) Nancy M. Elbaz et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Lecithin and PLGA-based self-assembled nanocomposite, Lecithmer: preparation, characterization, and pharmacokinetic/pharmacodynamic evaluation
- (2016) Seby Elsy Varghese et al. Drug Delivery and Translational Research
- Cationic solid lipid nanoparticles enhance ocular hypotensive effect of melatonin in rabbit
- (2015) Antonio Leonardi et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- LeciPlex, invasomes, and liposomes: A skin penetration study
- (2015) Sanket M. Shah et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Physicochemical characterization of epigallocatechin gallate lipid nanoparticles (EGCG-LNs) for ocular instillation
- (2014) Joana F. Fangueiro et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- The influence of new beta-adrenolytics nebivolol and carvedilol on intraocular pressure and iris blood flow in rabbits
- (2014) Dorota Szumny et al. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY
- A novel gene therapy vector based on hyaluronic acid and solid lipid nanoparticles for ocular diseases
- (2014) Paola Stephanie Apaolaza et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Development and Evaluation of Novel Surfactant-Based Elastic Vesicular System for Ocular Delivery of Fluconazole
- (2012) Indu Pal Kaur et al. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS
- A method for enhancing the ocular penetration of eye drops using nanoparticles of hydrolyzable dye
- (2011) Koichi Baba et al. JOURNAL OF CONTROLLED RELEASE
- Lecithin-Based Novel Cationic Nanocarriers (Leciplex) II: Improving Therapeutic Efficacy of Quercetin on Oral Administration†
- (2011) Abhijit A. Date et al. MOLECULAR PHARMACEUTICS
- Lecithin-based novel cationic nanocarriers (LeciPlex) I: fabrication, characterization and evaluation
- (2011) Abhijit A Date et al. Nanomedicine
- Ocular Drug Delivery
- (2010) Ripal Gaudana et al. AAPS Journal
- Effects of lipophilic emulsifiers on the oral administration of lovastatin from nanostructured lipid carriers: Physicochemical characterization and pharmacokinetics
- (2010) Chih-Chieh Chen et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Design and evaluation of liposomal formulation of pilocarpine nitrate
- (2010) S Rathod et al. INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Liposome coated with low molecular weight chitosan and its potential use in ocular drug delivery
- (2009) Ning Li et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Effect of Molecular Structure of Cationic Surfactants on Biophysical Interactions of Surfactant-Modified Nanoparticles with a Model Membrane and Cellular Uptake
- (2009) Chiranjeevi Peetla et al. LANGMUIR
- Challenges and solutions in topical ocular drug-delivery systems
- (2008) Maryam Ali et al. Expert Review of Clinical Pharmacology
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started